MIRANDA STEININGER: Open Payments
NPI 1639929763 · PALM HARBOR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $208 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $138 |
| Sumitomo Pharma America, Inc. | 3 | $73 |
| Boston Scientific Corporation | 1 | $44 |
| Azurity Pharmaceuticals, Inc. | 2 | $42 |
| Tempus AI, Inc | 1 | $31 |
| Telix Pharmaceuticals | 1 | $25 |
| Astellas Pharma US Inc | 1 | $20 |
| Procept Biorobotics Corporation | 1 | $19 |
| Antares Pharma, Inc. | 1 | $18 |
| Sagent Pharmaceuticals | 1 | $17 |
Products named: RYBREVANT, ORGOVYX, Axonics, AZMIRO, XT CDX, ILLUCCIX, ERLEADA, Xtandi.
Industry payments across FL — which companies pay providers there.
